FDA Inspection 1269249 — Bracco Suisse SA
The FDA completed an inspection of Bracco Suisse SA on Jul 4, 2024 in Plan-les-Ouates. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 4, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Plan-les-Ouates (Switzerland)
Additional details
Mutual Recognition Agreement (MRA)